More than 100 years
serving the industry
Life solutions
Energy solutions
Focus on
Our News
Biopharmaceutical Manufacturing For Neurological Therapies: Building The Manufacturing Backbone For Next-Generation Treatments
Neurological biologics require scalable cell culture, purification, clean utilities and GMP-ready facilities for reliable commercial production at global
More news
OUR SOLUTIONS
For your markets and industries
Food
& Ingredients
Food
& ingredients
Discover
Brewery &
Distillery
Brewery &
Distillery
Discover
Cosmetics
& Hygiene
Cosmetics
& Hygiene
Discover
Pharma & Biotech
Pharma & Biotech
Discover
Energy
Nuclear
Energy
Nuclear
Discover
Waste and biomass to energy
Waste and biomass to energy
Découvrir
Energy Transition
Energy Transition
Discover
Your projects
Our Achievements
Scaling up GLP-1 Production to Meet Global Demand: Boccard’s Contribution to a High-Growth Therapeutic Segment
As demand for GLP‑1 therapies grows in obesity and Type 2 diabetes care, manufacturers must rapidly scale production while meeting strict GMP requirements. This case study shows how Boccard delivered a robust and scalable GLP‑1 production line.
Monoclonal antibody (mAbs) production unit
Boccard was chosen for its expertise in monoclonal antibodies and disinfection as well as for its know-how in GMP design (good manufacturing practices).
Kvass extract production line for Coca-Cola in Ukraine
Coca-Cola’s R&D teams teamed up with our brewhouse experts to design a new technology for producing “Kvass” extracts in Ukraine. Coca-Cola’s R&D teams teamed up with our brewhouse experts to design a new technology for producing “Kvass” extracts in Ukraine.
Focus on
Our Expertise and Services
About
Boccard at a glance
You want
more information ?
Our Customers
They trust us
